November 2015

nov-2015-1

This November is #COPDAwarenessMonth. We are hosting several seminars in Scottsdale, Arizona, Pittsburgh, Pennsylvania,Nashville, Tennessee and Tampa, Florida. If you are near any of these locations, we invite you to join us to learn more about the therapies we offer for lung disease.

For more information about these and other upcoming events, visit our event calendar.

This month, we have three blogs to highlight our focus on COPD and you can find a link to each one below.

Helping you breathe easier,


Lung Institute 


nov-2015-2

Do you know that November is COPD Awareness Month, and World COPD Day is November 18, 2015? COPD is more common than you might think. It’s time to engage in the movement to bring greater awareness to COPD and treatment options. So, how well do you know COPD?

oct-2015-4


nov-2015-3

Cold weather can cause difficulties for anyone, but for people with COPD, changes in the weather can affect their health. Whether it is too hot or too cold, these changes can trigger symptoms. There are many reasons you have to brave the cold, such as going to work, walking to your car or enjoying the outdoors. Thankfully, there are ways for you and your lungs to stay warmer.

oct-2015-4


nov-2015-4

Upon being diagnosed with chronic obstructive pulmonary disease (COPD), and shortly before death on Feb. 27, 2015, actor Leonard Nimoy tweeted, “Not soon enough.” He was referring to his decision to quit smoking. Nimoy, made famous by playing Spock in Star Trek, had quit 30 years before, but the damage to his lungs had already been done…

oct-2015-4

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.